Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malcolm Mason

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
The Cochrane Database of Systematic Reviews|February 8, 2018
WITHDRAWN: Systemic treatments for metastatic cutaneous melanomaTom Crosby, Reg Fish, Bernadette Coles, et al.
The Cochrane Database of Systematic Reviews|April 15, 2011
Gemcitabine for unresectable, locally advanced or metastatic bladder cancerMike Shelley, Anne Cleves, Timothy J Wilt, et al.
The Cochrane Database of Systematic Reviews|April 24, 2004
Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy - a systematic review of the randomised trialsWai Man Sze, Mike Shelley, Ines Held, et al.
Lower Urinary Tract Symptoms|April 11, 2017
Degarelix Versus Goserelin Plus Bicalutamide in the Short-Term Relief of Lower Urinary Tract Symptoms in Prostate Cancer Patients: Results of a Pooled AnalysisMalcolm Mason, Pierre Richaud, Zsolt Bosnyak, et al.
European Journal of Cancer (Oxford, England : 1990)|January 13, 2010
Understanding the impact of public policy on cancer research: a bibliometric approachGrant Lewison, Arnie Purushotham, Malcolm Mason, et al.
Expert Review of Anticancer Therapy|October 31, 2014
Precision medicine for prostate cancerMyria Galazi, Alejo Rodriguez-Vida, Tony Ng, et al.
BJU International|March 21, 2012
Optimizing the care of patients with advanced prostate cancer in the UK: current challenges and future opportunitiesHeather Payne, Amit Bahl, Malcolm Mason, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 23, 2011
Expansion of a CD8(+)PD-1(+) replicative senescence phenotype in early stage CLL patients is associated with inverted CD4:CD8 ratios and disease progressionClaudia Nunes, Ryan Wong, Malcolm Mason, et al.
Medical Care Research and Review : MCRR|July 1, 2016
Patient Mobility for Elective Secondary Health Care Services in Response to Patient Choice Policies: A Systematic ReviewAjay Aggarwal, Daniel Lewis, Malcolm Mason, et al.
International Journal of Oncology|July 11, 2025
[Corrigendum] Dual roles of protein tyrosine phosphatase kappa in coordinating angiogenesis induced by pro-angiogenic factorsPing-Hui Sun, Gang Chen, Malcolm Mason, et al.
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
The Cochrane Database of Systematic Reviews|February 8, 2018
WITHDRAWN: Systemic treatments for metastatic cutaneous melanomaTom Crosby, Reg Fish, Bernadette Coles, et al.
The Cochrane Database of Systematic Reviews|April 15, 2011
Gemcitabine for unresectable, locally advanced or metastatic bladder cancerMike Shelley, Anne Cleves, Timothy J Wilt, et al.
The Cochrane Database of Systematic Reviews|April 24, 2004
Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy - a systematic review of the randomised trialsWai Man Sze, Mike Shelley, Ines Held, et al.
Lower Urinary Tract Symptoms|April 11, 2017
Degarelix Versus Goserelin Plus Bicalutamide in the Short-Term Relief of Lower Urinary Tract Symptoms in Prostate Cancer Patients: Results of a Pooled AnalysisMalcolm Mason, Pierre Richaud, Zsolt Bosnyak, et al.
European Journal of Cancer (Oxford, England : 1990)|January 13, 2010
Understanding the impact of public policy on cancer research: a bibliometric approachGrant Lewison, Arnie Purushotham, Malcolm Mason, et al.
Expert Review of Anticancer Therapy|October 31, 2014
Precision medicine for prostate cancerMyria Galazi, Alejo Rodriguez-Vida, Tony Ng, et al.
BJU International|March 21, 2012
Optimizing the care of patients with advanced prostate cancer in the UK: current challenges and future opportunitiesHeather Payne, Amit Bahl, Malcolm Mason, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 23, 2011
Expansion of a CD8(+)PD-1(+) replicative senescence phenotype in early stage CLL patients is associated with inverted CD4:CD8 ratios and disease progressionClaudia Nunes, Ryan Wong, Malcolm Mason, et al.
Medical Care Research and Review : MCRR|July 1, 2016
Patient Mobility for Elective Secondary Health Care Services in Response to Patient Choice Policies: A Systematic ReviewAjay Aggarwal, Daniel Lewis, Malcolm Mason, et al.
International Journal of Oncology|July 11, 2025
[Corrigendum] Dual roles of protein tyrosine phosphatase kappa in coordinating angiogenesis induced by pro-angiogenic factorsPing-Hui Sun, Gang Chen, Malcolm Mason, et al.
Pageof 8